IDH1 and central nervous system cancer: In the fifth edition of the WHO glioma classification, IDH-mutant diffuse astrocytomas are now classified as a single entity, including grades 2, 3, and 4, and are no longer subdivided into diffuse astrocytomas, anaplastic astrocytomas, and GBM.